FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1149386000: Product containing precisely ruxolitinib (as ruxolitinib phosphate) 20 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4555550018 Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
4555551019 Product containing precisely ruxolitinib (as ruxolitinib phosphate) 20 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has BoSS Ruxolitinib true Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Plays role Antineoplastic therapeutic role true Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Is a Ruxolitinib only product in oral dose form true Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has precise active ingredient Ruxolitinib phosphate true Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian dialect reference set

Back to Start